α-Parvin inhibitors belong to a distinctive chemical class that plays a pivotal role in modulating cellular functions by targeting α-parvin, a key component of the integrin-linked kinase (ILK) signaling pathway. Integrins are transmembrane receptors that mediate cell-extracellular matrix interactions, influencing diverse cellular processes such as adhesion, migration, and proliferation. Within the integrin signaling cascade, α-parvin acts as a crucial adaptor protein, forming a complex with ILK and PINCH to regulate downstream signaling events. Small molecules classified as α-parvin inhibitors are designed to selectively disrupt this protein-protein interaction, thereby impeding the transduction of signals essential for cellular responses.
α-parvin inhibitors often possess a tailored chemical framework that enables specific binding to the α-parvin protein. These molecules are meticulously designed to fit into the binding pocket of α-parvin, preventing its association with ILK and, consequently, interfering with the transmission of signals downstream. By impeding this interaction, α-parvin inhibitors exert influence over cellular processes governed by integrin signaling, offering a valuable tool for probing the intricacies of cell adhesion and migration. The development and study of α-parvin inhibitors contribute to the expanding landscape of chemical biology, shedding light on the nuanced mechanisms that underlie cellular behavior and providing insights into potential avenues for targeted interventions in various physiological contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK inhibitor, indirectly affects cell-matrix adhesion by altering actin cytoskeleton dynamics. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $179.00 $307.00 $455.00 $924.00 $1689.00 | 7 | |
Inhibits myosin II, potentially altering contractility and thus cell adhesion, where α-parvin is involved. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
MLCK inhibitor, may affect phosphorylation of myosin light chains, influencing adhesion process. | ||||||
PF-562271 | 717907-75-0 | sc-478488 sc-478488A sc-478488B | 5 mg 10 mg 50 mg | $306.00 $465.00 $1102.00 | 3 | |
FAK inhibitor, which could influence focal adhesion turnover and indirectly affect α-parvin's role. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Src family kinase inhibitor, which can modulate focal adhesion kinase signaling linked to α-parvin. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Another Src family kinase inhibitor, potentially affecting signaling pathways involving α-parvin. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $165.00 $214.00 $396.00 $617.00 $4804.00 | 19 | |
Metalloproteinase inhibitor, may affect extracellular matrix remodeling, influencing α-parvin's role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, can affect cell survival and adhesion pathways involving α-parvin. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor, can modulate downstream effects affecting cell adhesion. | ||||||
GSK 429286 | 864082-47-3 | sc-361200 sc-361200B sc-361200A | 1 mg 5 mg 10 mg | $39.00 $123.00 $230.00 | ||
ROCK inhibitor, similar to Y-27632, can alter the actin cytoskeleton and cell adhesion. |